Title:
BATTERY LEVEL STATE DETERMINATION METHOD
Document Type and Number:
WIPO Patent Application WO/2023/207671
Kind Code:
A1
Abstract:
The present application relates to the field of terminal devices. Disclosed is a battery level state determination method, which realizes that mapping is performed on the basis of usage data of a battery to obtain a target battery level after the mapping, thereby enhancing the stability of the battery, and protecting the battery. The method comprises: determining a battery protection voltage parameter according to usage data of a battery, the battery protection voltage parameter being used for changing an original voltage parameter corresponding to a battery level; according to the battery protection voltage parameter, determining a second mapping relationship between actual battery levels and target battery levels, and on the basis of the second mapping relationship and an actual charge level of the battery, determining a target battery charge level; or, according to the battery protection voltage parameter, determining the corresponding relationship between actual battery voltages and target battery levels, and on the basis of the corresponding relationship and an actual battery voltage of the battery, determining a target battery level.
Inventors:
LI YUAN (CN)
CUI RUI (CN)
RUAN JIAHAO (CN)
LIU YUTAO (CN)
WANG HAN (CN)
CUI RUI (CN)
RUAN JIAHAO (CN)
LIU YUTAO (CN)
WANG HAN (CN)
Application Number:
PCT/CN2023/088942
Publication Date:
November 02, 2023
Filing Date:
April 18, 2023
Export Citation:
Assignee:
HUAWEI TECH CO LTD (CN)
International Classes:
G01R31/388; G01R31/367; G01R31/389; G01R31/396
Foreign References:
| CN111602308A | 2020-08-28 | |||
| CN109342959A | 2019-02-15 | |||
| CN112622693A | 2021-04-09 | |||
| CN105277909A | 2016-01-27 | |||
| US20120112754A1 | 2012-05-10 |
Attorney, Agent or Firm:
TDIP & PARTNERS (CN)
Download PDF:
Previous Patent: DISPLAY PANEL AND DISPLAY APPARATUS
Next Patent: USE OF RS1 GENE IN PREPARING THERAPEUTIC AGENT FOR XLRS, AND THERAPEUTIC AGENT
Next Patent: USE OF RS1 GENE IN PREPARING THERAPEUTIC AGENT FOR XLRS, AND THERAPEUTIC AGENT